Estimating Lead Time and Overdiagnosis Associated with PSA Screening from Prostate Cancer Incidence Trends

DOI10.1111/j.1541-0420.2007.00825.xzbMath1274.92029OpenAlexW2042713079WikidataQ47787102 ScholiaQ47787102MaRDI QIDQ5450448

Roman Gulati, Ruth Etzioni, Donatello Telesca

Publication date: 20 March 2008

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1111/j.1541-0420.2007.00825.x

zbMATH Keywords

additive modelscancer screeningpenalized likelihoodconvolution modelslead time distribution

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)

Related Items (1)

Calibrating disease progression models using population data: a critical precursor to policy development in cancer control

Cites Work

• Unnamed Item
• Generalized additive models
• Flexible smoothing with \(B\)-splines and penalties. With comments and a rejoinder by the authors
• Estimation and Prediction for Cancer Screening Models Using Deconvolution and Smoothing
• Simplified Models of Screening for Chronic Disease: Estimation Procedures from Mass Screening Programmes
• Quasi-likelihood Estimation in Semiparametric Models
• Parametric estimation procedures for screening programmes: stable and nonstable disease models for multimodality case finding
• On the theory of screening for chronic diseases

This page was built for publication: Estimating Lead Time and Overdiagnosis Associated with PSA Screening from Prostate Cancer Incidence Trends